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Abstract
Protein translation is essential for all bacteria pathogens. It has also been a major focus of
structural and functional studies and an important target of antibiotics. Here we report our
attempts to biochemically reconstitute mycobacterial protein translation in vitro from purified
components. This mycobacterial translation system consists of individually purified recom-
binant translation factors fromMycobacterium tuberculosis (M. tuberculosis), purified
tRNAs and ribosomes fromMycobacterium smegmatis (M. smegmatis), and an aminoacyl-
tRNA synthetase (AARS) mixture from the cell-extract ofM. smegmatis. We demonstrate
that such mycobacterial translation system was efficient in in vitro protein synthesis, and
enabled functional comparisons of translational components between the gram-positive
Mycobacterium and the gram-negative E. coli. Although mycobacterial translation factors
and ribosomes were highly compatible with their E. coli counterparts,M. smegmatis tRNAs
were not properly charged by the E. coli AARSs to allow efficient translation of a reporter. In
contrast, both E. coli andM. smegmatis tRNAs exhibited similar activity with the semi-puri-
fiedM. smegmatis AARSs mixture for in vitro translation. We further demonstrated the use
of both mycobacterial and E. coli translation systems as comparative in vitro assays for
small-molecule antibiotics that target protein translation. While mycobacterial and E. coli
translation were both inhibited at the same IC50 by the antibiotic spectinomycin, mycobacte-
rial translation was preferentially inhibited by the antibiotic tetracycline, suggesting that
there may be structural differences at the antibiotic binding sites between the ribosomes of
Mycobacterium and E. coli. Our results illustrate an alternative approach for antibiotic dis-
covery and functional studies of protein translation in mycobacteria and possibly other bac-
terial pathogens.
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Introduction
TheWorld Health Organization estimates about one-third of the world’s population is infected
withMycobacterium tuberculosis (M. tuberculosis), the bacillus that causes pulmonary tubercu-
losis (TB). In 2013,>8.6 million people developed TB and 1.3 million people died from the dis-
ease [1]. Current multi-drug treatment takes lengthy 6–9 months and poor patient compliance
often leads to multi-drug resistant TB [2]. There is an urgent need to develop rapid diagnostic
tools and new classes of drugs to combat TB [3]. This calls for deeper understanding of theM.
tuberculosis biology and innovative approaches for antibiotic discovery.
Protein synthesis is essential for the pathogenesis ofM. tuberculosis and an important target
of antibiotics [4]. There are significant differences in the size and charge of the mycobacterial
ribosomal proteins from those of E. coli, and a recent cryo-EM structure of the 70S ribosome of
Mycobacterium smegmatis (M. smegmatis), a non-pathogenic laboratory model ofM. tubercu-
losis, has revealed a number of structural differences when compared to the 70S ribosome of E.
coli [5]. These studies suggest potential differences in ribosome functions betweenMycobacte-
rium and E. coli and the possibility of designing antibiotics that target only the gram-positive
M. tuberculosis. Additionally, a first-line tuberculosis drug, Pyrazinamide, has been recently
found to target the ribosomal protein S1 inM. tuberculosis, inhibiting the trans-translation
process [6]. Mistranslation of RNA polymerase proteins by the mycobacterial translational
machinery has been implicated in the phenotypic resistance to the antibiotic rifampicin [7]. In
spite of these recent progresses, the structural and functional studies ofM. tuberculosis protein
translation is still lacking, hampering the efforts to design new drugs targeting this core biologi-
cal pathway.
We have previously demonstrated a bottom-up approach that biochemically reconstitutes
the translation and transcription of E. coli and the translation of Thermus thermophilus for "in
vitro genetic" and comparative function studies [8–10]. In this work, we use the same approach
to reconstitute mycobacterial protein translation. We expressed recombinant translation fac-
tors ofM. tuberculosis in E. coli and individually purified theseM. tuberculosis proteins. To
obtain other mycobacterial translational components, we grewM. smegmatis cells and purified
ribosomes, tRNAs and amino acyl-tRNA synthetase (AARS) mixture from the cell extract. The
energy regeneration enzymes from the reconstituted E. coli translation system were used to
provide ATP and GTP for mycobacterial protein translation. T7 RNA polymerase was used to
couple transcription to translation and allow direct use of DNA templates. We demonstrate
that such reconstituted mycobacterial translation system not only was efficient in in vitro syn-
thesis of full-length proteins but also allowed functional studies of mycobacterial translation.
Since we had both mycobacterial and E. coli translation systems, we compared the translational
components between a gram-positive and a gram-negative bacterium by swapping the compo-
nents between two systems. We also used both systems in parallel to assay species-specific anti-
biotics that target protein translation. We perceive that our approach has a number of
advantages over other methods and represents a significant progress over previous studies. For
instance, genetic methods for investigating TB biology require specialized facilities to grow live
and infectiousM. tuberculosis cells, which can pose health hazards to researchers. The cell-
based assays for screening small-molecule inhibitors are not necessarily target-specific, gener-
ally dependent on cell-growth, and adversely affected by bacterial efflux pumps [11]. A previ-
ous attempt to biochemically reconstituteM. smegmatis translation has not involvedM.
smegmatis tRNAs and AARSs and thus cannot synthesize a full-length reporter protein for
convenient in vitro assays [12].
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Results and Discussion
Purification of recombinantM. tuberculosis translation factors expressed
in E. coli
The overall workflow for the reconstitution of mycobacterial protein translation is illustrated
in Fig 1. The genes for theM. tuberculosis translation factors (Tables 1 and 2) were de novo syn-
thesized and codon-optimized for expression in E. coli, and the recombinant proteins were his-
tidine-tagged for rapid purification on nickel-affinity chromatography. The initiation factors
(IF1, IF2), elongation factor G (G, from the fusA1 gene), release factors (RF1, RF2) and ribo-
some-recycling factor (RRF) were over-expressed as highly soluble proteins and purified to
near homogeneity after the nickel column as indicated by the SDS-PAGE analysis (S1A Fig).
The over-expressed initiation factor 3 (IF3) was insoluble, found exclusively in inclusion bodies
(IB), and was purified under the denaturation condition followed by in vitro renaturation (S1B
Fig). The elongation factor Ts (Ts) was expressed as partially soluble protein and a large por-
tion of the expressed protein remained in the pellet (S1C Fig). The soluble Ts was subsequently
purified from the nickel column. The elongation factor Tu (Tu) when over-expressed alone
was completely insoluble, and therefore was purified from inclusion bodies (IB) and renatured
in vitro (S1D Fig). Alternatively, we co-expressed both Tu and Ts genes under a single pro-
moter and purified the Tu/Ts complex to near homogeneity under the native condition after
several chromatographic steps (S1E Fig). This Tu/Ts complex was used for the reconstitution
Fig 1. A workflow for the biochemical reconstitution of mycobacterial protein translation.
doi:10.1371/journal.pone.0162020.g001
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of the complete mycobacterial translation system, while the separately purified Tu and Ts were
used for the functional conservation experiments in which they were substituted for the E. coli
Tu and Ts.
Purification of ribosomes, tRNAs and aminoacyl-tRNA synthetases from
M. smegmatis
Since M. smegmatis is a non-infectious close relative of M. tuberculosis, we growM. smegmatis
cells as the source for ribosomes, tRNAs and aminoacyl-tRNA synthethases (AARSs) (Fig 1).
Table 1. Sequence homology of the components involved in protein translation inMycobacterium and Escherichia coli.
Functions Protein names Mycobacterium gene names E. coli gene name % identity
Initiation Initiation factor 1 (IF1) infA infA 68
Initiation factor 2 (IF2) infB infB 33
Initiation factor 3 (IF3) infC infC 47
Elongation Elongation factor Tu (EF-Tu) tuf tufA 75
Elongation factor Ts (EF-Ts) tsf tsf 44
Elongation factor G (EF-G) fusA1 fusA 32
fusA2 - -
Elongation factor P (P) efp efp 42
Termination and recycling Release factor 1 (RF1) prfA prfA 45
Release factor 2 (RF2) prfB prfB 43
Release factor 3 (RF3) - prfC -
Ribosome-recycling factor (RRF) frr frr 41
Aminoacylation of tRNAs AlaRS alaS alaS 41
ArgRS argS argS 24
AsnRSa gatCAB asnS -
AspRS aspS aspS 48
CysRS cysS cysS 43
GlnRSa gatCAB glnS -
GluRS gltX gltX 36
GlyRS glyS glyQ, glyS -
HisRS hisS hisS 43
IleRS ileS ileS 26
LeuRS leuS leuS 37
LysRS lysS lysS 39
MetRS metS metS 26
PheRS pheS, pheT pheS, pheT 47, 33
ProRS proS proS 42
SerRS serS serS 38
ThrRS thrS thrS 41
TrpRS trpS trpS 53
TyrRS tyrS tyrS 46
ValRS valS valS 44
tRNAs - 45 tRNAs 86 tRNAs -
Ribosomes - - - -
aInMycobacterium, AspRS charges both tRNAasp and tRNAasn to yield Asp-tRNAasp and Asp-tRNAasn, respectively. The mis-charged Asp-tRNAasn is
immediately converted byM. smegmatis amidotransferase (a complex of three-gene product gatCAB) to Asn-tRNAasn. The similar process also occurs to
make Glu-tRNAglu and Gln-tRNAgln.
doi:10.1371/journal.pone.0162020.t001
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Based on high sequence homologies between the translational components of these two closely
related species, we expectedM. smegmatis ribosomes and tRNAs to be functionally compatible
withM. tuberculosis translation factors.M. smegmatis ribosomes were purified from the cell
extract via ultracentrifugation and the ribosomal proteins were analyzed on a SDS-PAGE gel
(S2A Fig). Compared to their E. coli counterparts,M. smegmatis ribosomal proteins exhibited
somewhat different band patterns and notably lacked the S1 protein, suggesting that S1 was
dissociated from the intactM. smegmatis ribosome during purification. The function of puri-
fiedM. smegmatis ribosomes was examined by substituting E. coli ribosomes in a reconstituted
E. coli system to synthesize a reporter. The reconstituted E. coli system did not generate any
reporter activity in the absence of ribosomes, but produced ~36% of the reporter activity with
M. smegmatis ribosomes as compared to E. coli ribosomes (S2B Fig). The data indicate that
purifiedM. smegmatis ribosomes (in spite of the lack of S1) were active in in vitro protein
synthesis.
Table 2. A complete list of components in the mycobacterial protein synthesis system.
Name Final concentration in in vitro translation reactions
M. tuberculosis translation factors IF1 2.7 μM
IF2 0.52 μM
IF3 0.60 μM
RF1 0.29 μM
RF2 0.37 μM
RRF 2.75 μM
EF-Tua 3.0 μM
EF-Tsa 3.0 μM
EF-G 0.45 μM
M. smegmatis AARSmix 0.96 mg/ml
M. smegmatis tRNAs 3 mg/ml
M. smegmatis ribosomes 2.4 μM
E. coli energy regeneration enzymes MK 0.26 μM
CK 0.22 μM
NDK 0.07 μM
PPA 0.04 μM
E. colimethionyl tRNA formyltransferase (MTF) 0.57 μM
T7 RNA polymerase 0.10 μM
Small molecules and buffer ATP 2 mM
GTP 2 mM
CTP 1 mM
UTP 1 mM
Creatine phosphate 20 mM
20 amino acids 0.3 mM
N10-formyl-tetrahydrofolate 0.02 mM
Spermidine 2 mM
DTT 7.2 mM
Mg(OAc)2 10 mM
K-Glutamate 100 mM
HEPES-KOH pH7.5 50 mM
a The puriﬁed EF-Tu/EF-Ts complex was used in the mycobacterial translation system. The complex contains an equal molar concentration of EF-Tu and
EF-Ts based on the estimation from the SDS-PAGE analysis.
doi:10.1371/journal.pone.0162020.t002
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The cell extract ofM. smegmatis cells was used for isolation of total tRNAs and enrichment
of AARSs (Fig 1). Total tRNAs were purified by phenol extraction and isopropanol fraction-
ation and shown to be comparable to the purified total E. coli tRNAs (S3A Fig). We expected
allM. smegmatis AARSs to be soluble in the cell extract and they could be enriched by ion
exchange chromatography. We collected and pooled the peak fractions from the elution of the
DEAE-ion exchange column (S3B Fig), and used the combined fractions as the source forM.
smegmatis AARSs. As suggested by the SDS-PAGE gel, this AARSs mixture likely contains
most of the cytosolic proteins ofM. smegmatis cells (S3B Fig). However, the AARS mixture
does not support any significant in vitro synthesis of a reporter luciferase in the absence of
translation factors (TF) or in the presence of translation factors (TF) and/or ribosomes without
purifiedM. smeg tRNAs (S4 Fig, second to fifth columns, and S9 Fig). A significant luciferase
activity was observed only in the presence of translation factors (TF), AARSs,purified tRNAs,
and ribosomes at the same time (S4 Fig, first column). The final protein concentration of the
AARS mixture in the mycobacterial translation system was 0.96 mg/ml (Table 2), which on its
own apparently contained sufficient aminoacyl tRNA synthetases, but not other factors to sup-
port in vitro synthesis. This is consistent with early studies of in vitro protein synthesis with the
E. coli cell extract which was normally used in excess of 10 mg/ml [13].
Reconstitution of mycobacterial protein translation from purified
components for efficient in vitro protein synthesis
For in vitro protein synthesis from a DNA template, we used T7 RNA polymerase to couple
the transcription from a T7 promoter to in vitro translation. We reconstituted mycobacterial
protein translation by mixing purified translation factors, ribosomes, tRNAs and the AARS
mixture following similar protocols as described previously for the reconstituted E. coli and
Thermus thermophilus translation systems [9, 14]. The final concentrations of the components
in the mycobacterial translation system are listed in Table 2 and are largely similar to those of
the reconstituted E. coli translation system with some modifications. For instance, we used a
higher concentration of mycobacterial tRNAs (3 mg/ml) compared to the E. coli translation
system (2 mg/ml). The mycobacterial AARSs was a mixture of native enzymes enriched from
theM. smegmatis cell extract in contrast to the E. coli translation system in which AARSs con-
sist of 20 individually purified recombinant proteins. We used the purified Tu/Ts complex
instead of separate proteins to achieve the highest in vitro synthesis activity in the mycobacte-
rial translation system.
The reconstituted mycobacterial translation system was tested for its ability to synthesize a
reporter from a DNA template. We found that the protein synthesis yield was ~19% of that of
the reconstituted E. coli system (Fig 2, third column). The lower synthesis yield of the mycobac-
terial translation system could be due to the inherent slow translation by mycobacterial ribo-
somes, asM. smegmatis grows almost 10 times slower than E. coli. Another possibility was the
non-optimal concentrations ofM. smegmatis AARSs for more efficient in vitro translation. The
M. smegmatis AARSs were purified as a mixture from the cell extract. This precludes the possi-
bility of adjusting the concentration of eachM. smegmatis AARS for maximal in vitro protein
synthesis as it was the case for the AARSs in the E. coli translation system. We also cannot
exclude the possibility that certain components that contribute to efficient protein translation
were missing, less active or present at low concentrations in the mycobacterial translation sys-
tem. To fully reconstitute mycobacterial protein translation, it will be necessary to individually
purify all mycobacterial tRNA synthetases as recombinant proteins, including aspartyl/gluta-
myl tRNAAsn/Gln amidotransferases (products of gatCAB genes) involved in the generation of
Asn-tRNAasn and Gln-tRNAgln (Table 1) [15, 16].
Biochemical Reconstitution of Mycobacterial Protein Translation
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Functional comparison of the translational components between
Mycobacterium and E. coli
The availability of both mycobacterial and E. coli translation systems allowed us to perform the
functional comparison of major translational components between gram-positive and gram-
negative bacteria. First, we comparedM. smegmatis ribosomes with E. coli ribosomes in the
reconstituted translation systems for in vitro synthesis of a reporter. When substituting for E.
coli ribosomes,M. smegmatis ribosomes in the E. coli translation system resulted in 34% of the
reporter activity compared to the complete E. coli translation system, suggesting thatM. smeg-
matis ribosomes are generally compatible with the translation components of E. coli (Fig 2,
compare the fourth column to the first column). These data are consistent with similar studies
that used Bacillus andM. smegmatis ribosomes in a reconstituted E. coli translation system [6,
17]. In comparison, when substituting forM. smegmatis ribosomes, E. coli ribosomes in the
mycobacterial translation system resulted in only 15% of the synthesis activity compared to
that of the complete E. coli translation system (Fig 2, compare the second column to the first
column). At first glance, it seemed that E. coli ribosomes were not very compatible with the
mycobacterial translation components. However, compared to the complete mycobacterial
translation system, E. coli ribosomes in the mycobacterial translation system resulted in ~76%
activity (Fig 2, compare the second column to the third column), suggesting that E. coli ribo-
somes were actually compatible with mycobacterial translation components.
Fig 2. Comparison of protein synthesis yields of mycobacterial and E. coli translation systems and
functional conservation of the mycobacterial and E. coli ribosomes.M. smegmatis:Mycobacterium
smegmatis;M. tuberculosis:Mycobacterium tuberculosis. The data are shown as means from at least two
independent reactions; error bars show s.d.
doi:10.1371/journal.pone.0162020.g002
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Next we investigated the compatibility of the translation factors, AARSs and tRNAs between
Mycobacterium and E. coli in the context of the mycobacterial translation (withM. smegmatis
ribosomes). A comparison of the amino acid sequence homology between mycobacterial and
E. coli translational components reveals varying degrees of the sequence identity (Table 1).
Thus it was interesting to investigate how the sequence identity corresponds to the functional
compatibility. First, we substituted mycobacterial translation factors (TFs) with their E. coli
counterparts in the mycobacterial translation system and analyzed the effect of each substitu-
tion on the activity of the translated reporter (S5–S7 Figs). Use of the E. coli initiation factors
(IFs) in the mycobacterial translation system decreased in vitro synthesis of the reporter by a
factor of 50% compared to the mycobacterial initiation factors (S5 Fig). On the other hand, E.
coli elongation factors (Tu and Ts) increased in vitro synthesis of the reporter compared to
their mycobacterial counterparts (S6 Fig, compare first and second columns). However, Tu
and Ts from mixed species reduced the amount of the synthesized reporter (S6 Fig, compare
third and fourth columns), suggesting Tu from one species was not very compatible with Ts
from another species. Similar hybrid experiments were performed with the ribosome release
factor (RRF) and elongation factor G (EF-G). However, in this case, no significant differences
were observed whether these factors were from the same species or mixed species (S7 Fig). Our
findings in general suggest that E. coli translation factors can substitute for their mycobacterial
counterparts in the mycobacterial system without significantly affecting in vitro synthesis of
the reporter. This functional conservation of translation factors betweenMycobacterium and E.
coli is consistent with a previous study that used a similar in vitro biochemical approach [12].
Though major translational components fromMycobacterium and E. coli were purified under
similar conditions and used in the same concentrations in these comparative studies, we cannot
exclude the possibility that one or a few mycobacterial components were less active and led to
the differences we observed in the results described above.
The most striking differences were observed when E. coli AARSs and/or tRNAs replaced
their mycobacterial counterparts in the mycobacterial translation system (Fig 3).M. smegmatis
AARSs seemed to be able to charge E. coli tRNAs at a similar efficiency asM. smegmatis
tRNAs, as judged by the similar reporter activities (albeit ~30% more for E. coli tRNAs) (Fig 3,
first and second columns). In contrast, E. coli AARSs resulted in almost a complete loss in the
reporter activity withM. smegmatis tRNAs (Fig 3, third column). Such drastic decrease in the
reporter activity did not seem to be caused by the use of E. coli translation factors (TFs) (Fig 3,
third column) since E. coli TFs were generally compatible with the rest of the mycobacterial
translation components (S5–S7 Figs). These data suggest that E. coli AARSs appeared to be
incapable of properly recognizingM. smegmatis tRNAs, possibly resulting in uncharged or
mis-charged tRNAs and the loss of the reporter activity. This incompatibility could be due to
the sequence (e.g., N73) and modification differences betweenM. smegmatis and E. coli tRNAs
in general, and non-discriminatingM. smegmatis aminoacyl tRNA synthetases and their
tRNAs in particular. For instance,M. smegmatis tRNAasp and tRNAasn were both charged by
the sameM. smegmatis non-discriminating aspartyl-tRNA sythetases (ND-AspRS) to yield
Asp-tRNAasp and Asp-tRNAasn, respectively. The mis-charged Asp-tRNAasn is immediately
converted byM. smegmatis amidotransferase to Asn-tRNAasn. The similar process also occurs
inM. smegmatis to make Glu-tRNAglu and Gln-tRNAgln. In contrast, E. coli AARSs consist of
20 individually purified synthetases, none of which is a non-discriminating synthetase. E. coli
tRNAasn and tRNAgln are charged by the specific (discriminating) aspariginyl-tRNA and gluta-
minyl-tRNA synthetases, respectively. The lack of amidotransferases in E. coli and the possibil-
ity of E. coli AARSs not being able to properly chargeM. smegmatis tRNAs due to the sequence
differences may account for the above observation (Fig 3, column 3).
Biochemical Reconstitution of Mycobacterial Protein Translation
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Though a number ofM. smegmatis AARSs have very low amino acid sequence identities
with those of E. coli AARSs (Table 1, e.g., Ile- and Met-tRNA synthetases at 26%), as far as the
synthesis of the active reporter is concern,M. smegmatis AARSs seemed to be able to properly
charge E. coli tRNAs (Fig 3, second column). The reason for this observation was not clear.M.
smegmatis AARSs in these experiments lacked Asn- and Gln-tRNA synthetases, and contained
essentially most soluble proteins from theM. smegmatis extract.M. smegmatis relies on a two-
step mechanism and amidotransferases to generateM. smegmatis Asn-tRNAAsn and Gln-
tRNAGln. Whether this process occurred with E. coli tRNAs in the mycobacterial translation
system remains to be tested. Future experiments will individually purify recombinantM. smeg-
matis AARSs including amidotransferases, which would allow us to address the above ques-
tions and at the same time fully reconstitute the mycobacterial protein translation.
Use of both mycobacterial and E. coli translation systems as a
comparative in vitro assay platform for testing antibiotics that specifically
targetM. tuberculosis protein translation
Structural studies of antibiotics-bound ribosomes have provides insights on the mechanisms of
translation inhibition by antibiotics. However, these studies are often limited to the model
organisms such as E. coli and Thermus thermophilus [18, 19]. To date, there is no high-resolu-
tion crystal structure of the ribosome from any pathogenic bacterium, hindering the rational
design of antibiotics that specifically target the pathogenic bacterium. The structural differ-
ences of the mycobacterial ribosome from the E. coli ribosome revealed by the cryo EM studies
Fig 3. Functional comparison of tRNA aminoacylation betweenMycobacterium and E. coli translation
systems. Note thatM. smegmatis aminoacyl-tRNA systhetases (AARSs) are a mixture of proteins from the
soluble fractions ofM. smegmatis cell extract, whereas E. coli AARSs consist of 20 individually purified
recombinant enzymes. The data are shown as means from at least two independent reactions; error bars
show s.d.
doi:10.1371/journal.pone.0162020.g003
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[5] suggest a possibility of screening small molecules that preferentially target the mycobacte-
rial translation.
Since it consists of only ribosomes and other translational components, a totally reconsti-
tuted bacterial protein synthesis system could be an ideal platform to assay and screen small-
molecules that target the translation process. With the availability of both mycobacterial and E.
coli translation systems, small molecules that target mycobacterial translation more specifically
than that of E. coli or vice versa could be readily identified. To demonstrate such feasibility, we
tested two known antibiotics, spectinomycin and tetracycline. We examined the inhibitory
effects of the antibiotics by measuring the activity of the reporter synthesized in either mycobac-
terial or E. coli translation system in the presence of different concentrations of the antibiotics.
We found that spectinomycin inhibited both mycobacterial and E. coli translation with a similar
in vitro efficacy (IC50 at ~1 μg/ml) (Fig 4). In contrast, tetracycline preferentially inhibited
mycobacterial translation with the estimated IC50 at ~2 μg/ml, while the IC50 for E. coli transla-
tion was ~40 μg/ml (Fig 4). Based on co-crystal structures with the ribosomes from E. coli or
Thermus thermophilus, both antibiotics inhibit protein translation by binding to the 30S ribo-
somal subunit [20–22]. Spectinomycin interacts with the head domain of the 30S subunit and
block translocation of mRNA and tRNAs on the ribosome [21]. On the other hand, tetracycline
interferes with aminoacyl-tRNA entrance by binding to the A site of the ribosome [22]. Our
data point to a possibility that there may be structural differences at the ribosomal A site
betweenM. smegmatis and E. coli that allow tetracycline to inhibit theM. smegmatis ribosomes
at much lower concentrations. However, we cannot rule out the possibility of other mechanisms
Fig 4. Use of the mycobacterial and E. coli translation systems as comparative in vitro inhibition assays for antibiotics
Spectinomycin (left panel) and tetracycline (right panel). The activities of the luciferase reporter synthesized in either
mycobacterial (black circles) or E. coli (white circles) are determined in the presence of various concentrations of the antibiotics.
The data are shown as means from at least two independent reactions; error bars show s.d.
doi:10.1371/journal.pone.0162020.g004
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of action. For instance, E. coli ribosomes may contain some species-specific ribosome-associ-
ated proteins that interfere with the tetracycline binding. Tetracycline may preferentially inter-
act with other translational components in the mycobacterial translation system and inhibit
protein translation through yet-to-identified mechanisms. We additionally tested the effects of
chloramphenicol, which prevents translation elongation by inhibiting peptidyl transferase
activity of ribosomes (S8 Fig). Both mycobacterial and E. coli translation were inhibited by
chloramphenicol with relatively similar in vitro efficacies (IC50 at ~5 and 1 μg/ml, respectively)
(S8 Fig).
We have previously demonstrated the use of the E. coli translation system for screening
small molecule inhibitors in 1536-well plates [10], mycobacterial translation system in this
study should be amenable to microplate-based high throughput assays. The total number of
assays will be determined by the amount of mycobacterial translation system one can produce
at reasonable costs. Most of the components of mycobacterial translation systems can be pro-
duced in fairly large amounts with small-scale cell cultures. The most limiting component isM.
smegmatis tRNAs, which we purified ~31 mg from 25 g cells, corresponding to 400 reactions
(25 μl per reaction). Therefore, mycobacterial translation system at the current scale may be
suitable for screening small molecules from targeted libraries.
Conclusions
This work illustrates a bottom-up biochemical approach for functional studies of the protein
translation machinery of mycobacteria and possible other bacterial pathogens. We have estab-
lished the feasibility that protein translation systems derived from different bacteria may be
used to identify species-specific antibiotics. Our goal has been to construct a translation system
consisting of the translational components entirely from an infectiousM. tuberculosis strain.
However, the current mycobacterial translation system is still a hybrid system in which AARS,
tRNAs and ribosomes are purified fromMycobacterium smegmatis, an easy-to-grow close rela-
tive ofM. tuberculosis. To achieve a complete biochemical reconstitution of protein translation
as well as transcription regulation of an infectiousM. tuberculosis strain, the future works
would involve purification of recombinantM. tuberculosis AARSs, recombinant amidotrans-
ferases, RNA polymerase holoenzyme and transcription factors, and isolation of ribosomes
and tRNAs fromM. tuberculosis cells. Such a completeM. tuberculosis cell-free system may be
used as an "in vitro genetic tool" [8, 10] for functional studies ofM. tuberculosis-specific genes
and pathways and for screeningM. tuberculosis-specific antibiotics.
Materials and Methods
Reagents
Unless specified otherwise, the chemicals were purchased from Sigma-Aldrich (St. Louis, MO),
the reagents including the reconstituted E. coli translation system (derived from PURExpress™)
were from New England Biolabs (NEB) (Ipswich, MA), and the primers were ordered from
Integrated DNA Technologies (Coralville, IA).
Cloning, expression and purification of recombinantM. tuberculosis
translation factors from E. coli
The genes encoding IF1, IF2, IF3, RF1, RF2, RRF, EF-Tu, EF-Ts, EF-G were synthesized by
GeneScript (Piscataway, NJ) with codons optimized for expression in E. coli. All genes were
cloned into the expression vector, pCOATexp, derived from pTYB1 vector (New England
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Biolabs), to allow expression of recombinant proteins with a C-terminal histidine-tag. The
expression vectors were transformed into E. coli strains ER3095 (New England Biolabs).
For each histidine-tagged protein, cells transformed with the expression vector were grown
at 37°C to OD600 of 0.6 in 2–6 L Luria-Bertani (LB) broth. Isopropyl-β-D-thiogalactoside
(IPTG) was then added to a final concentration of 0.1 mM and the cells were grown for an
additional 4–5 hr at 37°C. Cells were harvested by centrifugation and lysed by sonication in
lysis buffer (50 mM Tris-HCl, pH7.5, 300 mM KCl, 10 mMMgCl2, 20 mM imidazole, and 1
mM β-mercaptoethanol). Cell debris was removed by centrifugation at 16,000 g for 1 hr at 4°C
and the supernatant was applied to a 10 ml HisTrap FF column (GE healthcare, Piscataway,
NJ). After washing the column with 100 ml lysis buffer, the his-tagged protein was eluted with
a linear gradient of 20 mM to 250 mM imidazole in lysis buffer. Fractions containing the his-
tagged protein were combined and dialyzed against the storage buffer (25 mM Tris-HCl,
pH7.5, 100 mM K-glutamate, 10 mMMg(OAc)2, 30% glycerol, and 1 mM β-mercaptoethanol)
and stored frozen in small aliquots at -80°C.
In the case of IF3 and EF-Tu, both recombinant proteins were insoluble and mostly found
in the fractions of the inclusion bodies (IB) (S1B and S1D Fig). To solubilize the inclusion bod-
ies, cell pellet after centrifugation was washed twice with a washing buffer (20 mM Tris, pH7.5,
10 mM EDTA and 1% Triton X-100) and then dissolved in a denaturation buffer (20 mM Tris,
pH8.5, 4M urea). After centrifugation at 16,000 g for 30 min at 4°C to remove undissolved
materials, the supernatant was applied to a 10 ml HisTrap FF column (GE healthcare, Piscat-
away, NJ) equilibrated with the renaturation buffer 1 (20 mM Tris, pH8.5, 2M urea). After
washing the column with the renaturation buffer 1, IF3 or EF-Tu was eluted with a linear gra-
dient of 10 mM to 200 mM imidazole in the renaturation buffer 1. Fractions containing the IF3
or EF-Tu protein were combined and dialyzed against the renaturation buffer 2 (20 mM Tris,
pH8.5, 1M urea) and then the renaturation buffer 3 (20 mM Tris, pH8.5). The solubilized pro-
teins were stored frozen in small aliquots at -80°C
M. tuberculosis EF-Tu was also purified as a complex withM. tuberculosis EF-Ts. In this
case, the genes forM. tuberculosis EF-Ts and EF-Tu were cloned into the MCS1 and MCS2 of
pETDuet-1 respectively. A peptide MGSSHHHHHHSQDPNS was engineered to the N-terminus
of EF-Ts to add a 6xHis-tag and a linker region to facilitate the affinity purification of the
EF-Tu/Ts complex. The plasmid was transformed into Rosetta DE3 competent cells. The cells
were grown at 37°C to OD600 = 1.0 and then induced by adding IPTG to a final concentration
of 0.5mM. The induction was continued at 25°C overnight with shaking. Cells were harvested
by centrifugation at 3,000 rpm for 20 mins. The cell pellet was re-suspended in the Lysis buffer
containing 50 mM of Tris pH 8.0, 150 mM of NaCl and 10mM of Imidazole. Cells were dis-
rupted by ultrasonication on ice, followed by centrifugation at 15,000rpm for 30mins at 4°C to
remove the cell debris. The supernatant was loaded to a 3ml Ni-NTA(Qiagen) pre-equilibrated
with the Lysis buffer. The resin was washed with 20 column volumes Lysis buffer and then
eluted with the elution buffer containing 50 mM Tris 8.0, 150 mMNaCl and 100 mM Imidazol.
The eluate was immediately dialyzed against a buffer containing 50mM of Tris pH 8.0 and
150mM of NaCl. The sample was loaded to a 5-ml anion exchange column Hitrap Q HP (GE
healthcare) and eluted with a linear gradient of 150 mM to 1M NaCl. Two peaks from the ion
exchange chromatography were observed, both of which contain protein species corresponding
to the molecule weights of EF-Tu and EF-Ts. Mass spectrometry analysis was performed to
identify that the first peak contained the complex of of E. coli EF-Tu andM. tuberculosis EF-Ts,
whereas the second peak contained the complex ofM. tuberculosis EF-Tu andM. tuberculosis
EF-Ts. Therefore, the second peak was collected and subjected to a size-exclusion column
Superose 6 10/300 GL (GE healthcare). The eluate containing theM. tuberculosis EF-Tu/Ts
complex was pooled and concentrated to ~30 mg/ml.
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The protein concentrations were determined by Bradford Assay. For SDS-PAGE analyses,
aliquots were taken from the in vitro translation reactions and run on a 10–20% Tris–glycine
SDS–PAGE gels (Life Technologies, Carlsbad, CA).
Purification ofM. smegmatis ribosomes and testing the protein synthesis
activity
M. smegmatis ribosomes were purified using established protocols with minor modification [9,
23]. All buffers and purification procedures were at 4°C, unless otherwise noted. Specifically,
M. smegmatis(ATCC 19420) cells were grown in small-scale fermentation (10 L) in NEB fer-
mentation facility. The culture was cooled rapidly and the cells were harvested by centrifuga-
tion. Fresh cell paste (80 g) was washed twice in 200 ml of wash/lysis buffer (20 mM Tris-HCl,
pH7.5, 100 mMNH4Cl, 10.5 mMMgCl2, 0.5 mM EDTA, 6 mM β-mercaptoethanol) and then
resuspended in 150 ml of the same wash/lysis buffer. The cells were disrupted at 40 kpsi by a
cell disruption system (Constant Systems, Low March, Daventry, Northants, United Kingdom)
and cell debris was removed by centrifugation at 30,000 g for 1 hr. The supernatant was centri-
fuged again at 30,000 g for additional 30 min and saved as theM. smegmatis S30 extract. For
ribosome purification, 25 ml of the S30 extract was overlayered onto 13 ml of a sucrose cushion
(Cushion I: 20 mM Tris-HCl, pH7.5, 10.5 mMMgCl2, 0.5 mM EDTA, 1.1 M Sucrose, 6 mM β-
mercaptoethanol, 2mM DTT) in each ultracentrifuge tube, and the ultracentrifugation was
conducted in a Beckman SW28 rotor at 28,000 rpm for 22 hr. The pellet containing the ribo-
some was solubilized in the ribosome storage buffer (25 mM Tris-OAc, pH7.5, 100 mM
NH4OAc, 10 mMMg(OAc)2, 6 mM β-mercaptoethanol, 2mM DTT) by overnight incubation
at 4°C. The purified ribosome was concentrated to an appropriate concentration and stored
frozen in aliquots at -80°C. The final concentration of the purified ribosome was measured at
A260. Aliquots of the purifiedM. smegmatis and E. coli ribosomes were loaded on a SDS-PAGE
gel for comparison and purity check (S2A Fig).
The activity of the purifiedM. smegmatis ribosomes was tested for in vitro synthesis of a
reporter in a reconstituted E. coli system in which E. coli ribosomes were removed. The protein
synthesis reactions (25μl) were set up by mixing the reconstituted protein synthesis system
containing 2.4μM either E. coli orM. smegmatis ribosomes with RNase inhibitor (2 units) and
200 ng reporter DNA templates (pUCAT7Fluc) expressing the firefly luciferase (Fluc) under a
T7 promoter. The reaction mixtures were incubated at 37°C for 4 hr and aliquots were taken
for luciferase assays.
Purification of totalM. smegmatis tRNAs and enrichment ofM.
smegmatis AARSs from theM. smegmatis cell extract
1. Purification of totalM. smegmatis tRNAs.M. smegmatis cells were lysed as described
above in the ribosome purification protocol. The lysate was clarified by low speed centrifu-
gation (10000 rpm for 20 minutes) in a Sorvall centrifuge. Clarified lysate was divided in
equal halves and one half was used for total tRNAs preparation whereas the another half
was used for AARSs enrichment (see below). Briefly, The clarified cell lysate was passed
through a DEAE column equilibrated with 50 mM Tris-HCl, pH7.5, 0.5 mM EDTA, 6 mM
β-mercaptoethanol, 50mM NaCl. Fractions were eluted with a linear gradient of 100 mM to
1500mMNaCl in the aforesaid equilibrium buffer. All the fractions exhibiting UV absor-
bance (representing either soluble proteins, nucleic acids or a mix of both) were pooled and
diluted with the aforesaid equilibrium buffer and mixed with an equal volume of the satu-
rated phenol solution (pH 6.6) and incubated at 37°C for 30 min. After centrifugation at
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13,000 g for 15 min, the upper layer was collected and subject to a second phenol extraction
and centrifugation step. The nucleic acids (DNA and RNA) in the upper layer were then
precipitated by adding 0.1 volume of 3M sodium acetate (pH5.3) and 2.5 volume of cold
ethanol, and incubating overnight at -20°C. Following centrifugation at 13,000 g for 30 min,
the pellet was dried and then dissolved in 70 ml of 0.3 M sodium acetate (pH7.0). To precip-
itate DNA and high molecular weight RNA, isopropanol (38 ml) was added slowly in drops
with a needle at 4°C. After centrifugation at 13,000 g for 30 min, the supernatant (~108 ml)
was collected and mixed with 31 ml of isopropanol. Following centrifugation at 13,000 g for
30 min, pellet of the precipitated tRNAs was dried and dissolved in H2O. The final concen-
tration of total tRNA was measured at A260.
2. Enrichment ofM. smegmatis AARSs from the cell lysate. We applied the clarified lysate
on a DEAE-cellulose column equilibrated with 50 mM Tris-HCl, pH7.5, 0.5 mM EDTA, 6
mM β-mercaptoethanol followed by elution against a linear gradient of 0.0–0.5M NaCl in
the same buffer. The protein fractions were pooled and precipitated with 100% ammonium
sulfate. The precipitate was recovered by low speed centrifugation (15,000g for 30 minutes),
dissolved in a buffer containing 50 mM Tris-HCl, pH7.5, 0.5 mM EDTA, 6 mM β-mercap-
toethanol, 20 mM NaCL and dialyzed twice against the same buffer. The resulting prepara-
tion enriched in mycobacterial AARSs was used for the reconstitution of mycobacterial
protein translation.
Reconstitution of mycobacterial protein translation from purified
components
Following a protocol similar to that of the reconstituted E. coli translation system, the myco-
bacterial translation was reconstituted by mixing the purifiedM. tuberculosis translation fac-
tors,M. smegmatis AARSs mixture,M. smegmatis tRNAs and ribosomes, E. coli energy
regeneration enzymes, T7 RNA polymerase (for coupling transcription to translation), and
small molecules (see Table 2 for the complete list and concentrations).
The protein synthesis reactions (typically 25μl each reaction) were set up by mixing the
reconstituted protein synthesis system with RNase inhibitor (2 units) and 200 ng reporter
DNA templates (pUCAT7Fluc) expressing the firefly luciferase (Fluc) under a T7 promoter.
The reaction mixtures were incubated at 37°C for 4 hr and aliquots were taken for the luciferase
assays.
Functional comparison of the translational components between
Mycobacterium and E. coli
The experiments swapping the mycobacterial and E. coli translation components (translation
factors (TFs, individually or all together), AARSs, tRNAs, ribosomes) were primarily con-
ducted in in vitro translation reactions that synthesized the Fluc reporter (Figs 2 and 3 and S2–
S7 Figs). The mycobacterial translation components were either removed or replaced by equal
amounts of corresponding E. coli counterparts.
In vitro antibiotic inhibition assays in mycobacterial and E. coli translation
systems
The assays (25μl each assay) were set up by mixing the mycobacterial or E. coli translation sys-
tem with RNase inhibitor (2 units), 200 ng reporter DNA templates (pUCAT7Fluc) expressing
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the firefly luciferase (Fluc) and various amounts of spectinomycin or tetracycline. The reaction
mixtures were incubated at 37°C for 4 hr and aliquots were taken for the luciferase assays.
Luciferase activity assay
The activity of the Fluc reporter was assayed using the Luciferase Assay System (Promega,
Madison, WI) in a microplate luminometer (Centro LB 640, Berthold Technologies, Oak
Ridge, TN) according to manufacturers’ instructions. Protein synthesis reactions were diluted
10-fold in 1x cell culture lysis reagent (Promega, Madison, WI) containing 1 mg/ml BSA. Ali-
quots (5 μl) were added in triplicate to a microplate for the luciferase assay in the luminometer.
Supporting Information
S1 Fig. SDS-PAGE analysis of the purification ofM. tuberculosis translation factors. (A)
These solubleM. tuberculosis translation factors were purified under native conditions to near
homogeneity after the nickel column; (B) IF3 were insoluble, mostly present in inclusion bodies
(IB) and purified under denaturation conditions; M: molecular weight; (C) EF-Ts (Ts) was
partially soluble and present in both soluble fraction (S) and inclusion bodies (IB). Ts was puri-
fied under native conditions without denaturation. L: lysate; FT: flow through fraction; (D)
EF-Tu (Tu) when expressed alone was mostly insoluble and therefore purified under denatur-
ation conditions; The elution fractions from the nickel column are shown here. (E) When co-
expressed, EF-Tu and EF-Ts are soluble and form a 1:1 complex, which was purified over sev-
eral columns. The final elution fractions are shown here.
(PPTX)
S2 Fig. Purification ofM.smegmatis ribosomes. (A) SDS-PAGE analysis ofM.smegmatis and
E. coli ribosomes. (B) Reporter activity assays ofM. smegmatis ribosomes in the E. coli transla-
tion system in which E. coli ribosomes were replaced byM. smegmatis ribosomes.
(PPTX)
S3 Fig. Purification of total tRNAs and AARSs. (A) Agarose gel analysis of purifiedM.smeg-
matis total tRNAs (lane 1) in comparison with purified E. coli total tRNAs (lane 2). (B)
DEAE-column elution profile of the cell extract ofM.smegmatis and SDS-PAGE analysis of
the elution peak fractions, which we expected to contain allM.smegmatis aminoacylation
enzymes (AARSs).
(PPTX)
S4 Fig. Reporter activity assays ofM.smegmatis AARS mixture and purifiedM.smegmatis
tRNAs in the mycobacterial translation reactions.M. tuberculosis translation factors (TFs)
andM.smegmatis ribosomes were used. The luciferase activity below 1000 is considered to be
the background.
(PPTX)
S5 Fig. Comparison of E. coli andM.smegmatis initiation factors (IFs) in the mycobacterial
translation system for the synthesis of a luciferase reporter.
(PPTX)
S6 Fig. Comparison of E. coli andM.smegmatis elongation factor Tu (Tu) and elongation
factor Ts (Ts) in the mycobacterial translation system for the synthesis of a luciferase
reporter.
(PPTX)
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S7 Fig. Comparison of E. coli andM.smegmatis ribosome-release factor (RRF) and elonga-
tion factor G (EF-G) in the mycobacterial translation system for the synthesis of a luciferase
reporter.
(PPTX)
S8 Fig. Effect of chloramphenicol on the reporter synthesis in E. coli (open circle) andM.
smegmatis (black circle) translation systems. The activities of the synthesized reporter were
determined in the presence of various concentrations of the antibiotic. The data are shown as
means from two independent reactions; error bars show s.d.
(PPTX)
S9 Fig.M. smegmatis AARS mixture alone or with ribosomes was not sufficient to synthe-
size a significant amount of the reporter protein inM. smegmatis translation system.
(PPTX)
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